Updated Efficacy Data and MRD Analysis According to Risk Status in Newly Diagnosed Myeloma Patients Treated with Carfilzomib + Lenalidomide or Cyclophosphamide (FORTE Trial).Francesca Maria Gay,Robin Foa,Pellegrino Musto,Chiara Cerrato,Barbara Gamberi,Elena Zamagni,Angelo D. Palmas,Antonio Spadano,Paola Omede,Tommaso Caravita,Nicola Giuliani,Stelvio Ballanti,Francesca Patriarca,Rossella Troia,Massimo Gentile, Giovanni Desabbata,Letizia Canepa,Antonio Palumbo,Michele Cavo,Mario BoccadoroJournal of clinical oncology（2018）引用 4|浏览95暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
